CME Market Regulation clarifies Rule 575 for pro rata markets
Updated
Updated · The National Law Review · May 5
CME Market Regulation clarifies Rule 575 for pro rata markets
6 articles · Updated · The National Law Review · May 5
On 4 May, it issued Advisory Notice RA2602-5, the seventh Rule 575 guidance since 2014, and added Q&A 12 to address uncertainty left by Q&A 11.
The update defines qualifying financial assets, excludes encumbered or approval-dependent funding, and says orders at the top of book or within CME Globex non-reviewable ranges are at risk of immediate execution.
Questions remain over whether hedging capacity can mitigate enforcement, how immediate-execution thresholds will be applied, and why traders within clearing-firm credit limits may still fail Market Regulation's hypothetical margin-call test.
As CME tightens its financial rules against 'spoofing,' could this inadvertently stifle the very market liquidity it aims to protect?
With regulators clarifying rules on disruptive trading, will AI become the next battleground for detecting market manipulation?